The Limited Times

Now you can see non-English news...

Smallpox vaccination - mode of action, protection and side effects

2022-06-03T02:58:13.273Z


Smallpox vaccination - mode of action, protection and side effects Created: 2022-06-03 04:48 By: Anna Lorenz To stop the spread of monkeypox, the return of smallpox vaccination is being discussed. The vaccine is expected to offer good protection but is also known for its side effects. Munich – The cases of monkeypox are increasing in Europe. The virus, which is associated with lesions in the f


Smallpox vaccination - mode of action, protection and side effects

Created: 2022-06-03 04:48

By: Anna Lorenz

To stop the spread of monkeypox, the return of smallpox vaccination is being discussed.

The vaccine is expected to offer good protection but is also known for its side effects.

Munich – The cases of monkeypox are increasing in Europe.

The virus, which is associated with lesions in the form of smallpox, is currently being viewed critically in view of the lessons of the corona pandemic.

The question of how the administration of the common smallpox vaccine could counteract the spread of the infection is now the subject of political debate.

Smallpox vaccination against monkeypox: Germany stores millions of vaccine doses, Lauterbach orders 44,000 Imvanex syringes

The smallpox virus family is large.

As can be read in the textbook

Medical Virology

(Doerr et al.), However, if

the

Smallpox is the variola virus (Orthopoxvirus variolae), the natural host of which is man.

This virus has been considered defeated since the WHO's large-scale eradication campaign in the 1960s.

As the organization reported in 1987, a man from Somalia infected on October 26, 1977 was the last known sick person.

Other types of smallpox whose hosts are animals (animal smallpox) continued to exist - including monkeypox, discovered in 1958.

Humans are not the actual target of the virus (false host);

the monkeypox virus, known as orthopoxvirus simiae or monkeypox virus (MPV), was previously not known to be particularly contagious.

The infections with MPV, which led to epidemics in the Congo in both the 1980s and 1990s,

Since the variola virus, which is a threat to humans and also known as smallpox, was believed to have been eradicated, as the

Pharmazeutische Zeitung

comprehensively explains, vaccine production was largely stopped over the years due to a lack of demand.

The only preparation available as a vaccine is Imvanex.

The active ingredient is produced by the Danish vaccine company Bavarian Nordic and has been approved in the EU as a vaccine against smallpox since 2013.

According to Health Minister Karl Lauterbach (SPD), Germany has now ordered “up to 40,000 doses” of Imvanex, which is approved for monkeypox in the USA.

In addition, according to a report by the Federal Ministry of Health, which is available to the

dpa

, Germany stores 100 million smallpox vaccinations, two million of them for the WHO - it is not known which preparation is involved.

According to the

medical journal

, the doses have so far been kept in reserve in case the variola virus returns.

Monkeypox: Smallpox vaccination once caused serious side effects

With cases of monkeypox now appearing internationally, the question arises as to whether preventive smallpox vaccination could stop MPV.

Smallpox vaccination was compulsory for one-year-olds until 1975 in the FRG and until 1982 in the GDR.

A vaccine was administered with the vaccinia virus, which is very similar to the variola virus;

the vaccine protection brought, according to the

medical journal

, also a "(cross) immunity (...) against the closely related cowpox or monkeypox".

However, since the vaccination was sometimes associated with serious side effects and even deaths, it was soon discontinued with the eradication of smallpox proclaimed by the WHO.

By 1980 (GDR) at the latest, however, there were no more primary vaccinations in Germany.

This means that almost everyone under the age of 50 in this country is not vaccinated against smallpox.

According to Lauterbach, people who have been vaccinated against smallpox should be well protected.

Normal smallpox vaccine is "but not suitable to fight monkeypox," said the health minister.

RKI boss Wieler agrees and draws attention to the side effects of smallpox vaccination.

The monkeypox vaccine has significantly fewer side effects, according to the RKI boss.

also read

Omicron subvariant BA.5 is spreading in Portugal – is there a risk of a summer wave in Germany?

Monkeypox in Germany: Lauterbach announces isolation – countries “take the situation seriously”

While the head of the World Medical Association, Frank Ulrich Montgomery, stated to the

newspapers of the Funke media group

that people who were vaccinated back then also had "good protection" against monkeypox, the

Pharmazeutische Zeitung

reports that several physicians, including Professor Dr.

Leif Erik Sander from the Berlin Charité and Karl Simpson, director of the British life science company JKS Bioscience Limited, have different views.

As early as July 2020, Simpson had postulated in the journal Vaccine that around 70 percent of the world's population was no longer protected against smallpox, not least because of declining immunity.

In 2022, a research team led by scientist Eveline Bunge published a recent analysis in the journal Plos Neglected Tropical Diseases, evaluating monkeypox cases between 1970 and 2019.

The number of illnesses increased tenfold during this time;

however, the age of those affected has increased significantly.

This result, according to which monkeypox would be of “global relevance”, strongly suggests that existing vaccination protection is declining.

The Robert Koch Institute (RKI) also suspects that infection through contact with MPV is becoming increasingly likely due to the decreasing protection against smallpox vaccination.

The institute points out that the "(primary) transmissibility from person to person (...

Smallpox vaccination: yes or no?

Potential vaccination for monkeypox remains a cost-benefit analysis

To what extent the vaccination designed for smallpox is advisable in view of the current monkeypox cases depends on many, largely unanswered questions.

The fact that MPV seems to spread in such an atypical way is "quite unusual and must (...) be examined in detail and any further spread closely monitored," according to the

Friedrich

Loeffler Institute (FLI).

on Thursday, May 19, 2022. The major concern here is that the virus may have changed structurally;

According to the Pharmazeutische Zeitung

, spontaneous mutations are not uncommon

in poxviruses .

In this case, it would be questionable how well Imvanex could help against monkeypox.

Side effects of the new vaccine, which according to the

Paul Ehrlich Institute (PEI)

is only administered from the age of 18, can possibly only be statistically assessed in large vaccination groups.

On the other hand, the US health authority

Centers for Disease Control and Prevention (CDC)

points out that data from Africa have shown that the smallpox vaccine Imvanex - known in the USA as Jynneos - prevents up to 85 percent of cases of monkeypox.

According to the CDC's Jennifer McQuiston, "Those who are at high risk of serious illness, as well as contacts and medical staff, would benefit most from vaccination.

According to dpa

, Federal Health Minister Karl Lauterbach (SPD)

has already pointed out the benefits that vaccination could bring not only preventively, but also for those who are already infected.

CDC epidemiologist John Brooks stressed, according to

AFP

also that immunocompromised people or people suffering from skin diseases are more at risk of monkeypox.

Previous data indicate that same-sex sexual intercourse among men is a possible, but not exclusive, route of infection.

Following this, Montgomery warned younger people in particular with more frequent changing sexual partners to exercise caution.

(askl)

Source: merkur

All news articles on 2022-06-03

You may like

Trends 24h

News/Politics 2024-03-28T06:04:53.137Z

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.